AIDS Research and Human Retroviruses · 2007 · 72 citations · 15 references
Veterinary MedicineImmunologyInfectious DiseasesImmunology Of Infectious DiseasesVaccine ImmunologyVaccinologyClinical Development Of VaccinesClinical Vaccine TrialsImmune MonitoringVaccine EfficacyBlood Sample CollectionMulticenter Clinical TrialsPeripheral Blood Mononuclear Cell ProcessingT Cell Response InductionT-cell Immune ResponsesT-cell Mediated ResponsesVaccine Candidate AntigensVaccine Clinical Trial Design
Quantitative analysis of cell-mediated immune responses induced by candidate HIV vaccines requires robust procedures for collecting and processing human peripheral mononuclear blood cells (PBMCs). We evaluated several parameters in order to optimize a sample handling process that would be suitable for a multicenter clinical trial. Among the findings, systematic increases in the magnitude of IFN-gamma ELISpot responses were observed when the time from blood collection to PBMC freezing was reduced to <12 h. By implementing these improvements within an ongoing clinical trial, the estimated immunologic response rates to an adenovirus- based HIV vaccine increased by more than 20 percentage points to approximately 80% of the vaccine recipients against any of the vaccine antigens and the average levels of T cell response improved more than 3-fold. These studies establish the importance of optimal conditions for PBMC collection and handling to the success of a clinical development program.
15
Richard A. Koup, Jeffrey T. Safrit, Yaming Cao et al. · Journal of Virology · 1994 · 2.5K citations · Full text
John W. Shiver, Tong‐Ming Fu, Ling Chen et al. · Nature · 2002 · 1.2K citations · Full text
HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women
Sarah Rowland‐Jones, Julian Sutton, Koya Ariyoshi et al. · Nature Medicine · 1995 · 741 citations